Metformin × body weight & composition

Observational studyJournal of diabetes investigation2016

Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38).

Azuma Kanatsuka et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 2016

No range given

Reported lower body weight & composition, no range given

−25.0

As reported

difference −25.0, no interval

No range given

Reported higher body weight & composition, no range given

+25.0

As reported

difference 25, no interval

Two numbers in the abstract

the abstract, start to end

in the patients stratified by a BMI of <25 (P = 0.00), and decreased with metformin in the patients with a BMI >25 (P = 0.00).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Body weight & composition
−25.0
Body weight & composition
25
MetforminSulfonylureas & glinidesBody weight & composition
1 / 3

13 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27330726